Published in Am J Ophthalmol on March 15, 1992
Inhibition of PCR by aqueous and vitreous fluids. J Clin Microbiol (1995) 2.35
Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis. Br J Ophthalmol (2003) 1.79
Detecting herpesvirus DNA in uveitis using the polymerase chain reaction. Br J Ophthalmol (1996) 1.01
Diagnostic assays in cytomegalovirus retinitis: detection of herpesvirus by simultaneous application of the polymerase chain reaction and local antibody analysis on ocular fluid. Br J Ophthalmol (1996) 0.87
Diagnostic assays in cytomegalovirus retinitis. Br J Ophthalmol (1996) 0.83
Prophylactic vitrectomy for acute retinal necrosis. Jpn J Ophthalmol (2009) 0.81
[Acute retinal necrosis from the virologist's perspective]. Ophthalmologe (2009) 0.77
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells. Proc Soc Exp Biol Med (1967) 5.61
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol (1980) 3.40
Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn (1967) 2.89
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology (2006) 2.75
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
The microbiological flora of penile ulcerations. J Infect Dis (1978) 2.43
Partner's influence on patient preference for treatment in early prostate cancer. BJU Int (2003) 2.33
Indirect hemagglutination test for detection of antibodies to Cytomegalovirus. Appl Microbiol (1971) 2.28
The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology (1994) 2.25
Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein trafficking and virion envelopment. J Virol (1988) 2.22
The acute retinal necrosis syndrome. Part 2: Histopathology and etiology. Ophthalmology (1982) 2.15
Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect Immun (1978) 2.15
Surgical management of macular holes: a report by the American Academy of Ophthalmology. Ophthalmology (2001) 2.14
Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J Virol (1997) 2.14
Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J Virol (1985) 2.09
Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. Am J Ophthalmol (2001) 2.06
Multidisciplinary approach to deep-seated lesions requiring radiologically-guided fine-needle aspiration. Diagn Cytopathol (1998) 2.04
Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay. J Immunol (1976) 2.03
Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology (1987) 2.03
Primary Epstein-Barr-virus infections in acute neurologic diseases. N Engl J Med (1975) 2.02
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology (2000) 1.99
Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol (1994) 1.99
Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. Eye (Lond) (2008) 1.96
The floppy eyelid syndrome. Am J Ophthalmol (1981) 1.95
Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun (1983) 1.95
Exogenous fungal endophthalmitis. Ophthalmology (1988) 1.90
Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J Virol (1995) 1.89
Topical anesthetic abuse. Ophthalmology (1990) 1.86
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Pseudophakic endophthalmitis. Diagnosis and management. Ophthalmology (1986) 1.82
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol (1992) 1.81
Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75
The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology (1980) 1.72
Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology (1995) 1.72
Method for typing antisera to Herpesvirus hominis by indirect hemagglutination inhibition. Appl Microbiol (1971) 1.70
How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis (1978) 1.70
Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics (1981) 1.69
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65
Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol (1979) 1.64
Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J Virol (1998) 1.62
Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis (1995) 1.60
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol (1986) 1.59
Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system. J Virol (1993) 1.58
Combined doppler and phased-array echocardiographic estimation of cardiac output. Circulation (1981) 1.57
Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) (2009) 1.57
Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56
Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J (1990) 1.53
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol (2001) 1.53
Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology (2001) 1.50
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis (1991) 1.50
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology (1984) 1.49
Site-directed mutagenesis of herpesvirus glycoprotein phosphorylation sites by recombination polymerase chain reaction. PCR Methods Appl (1992) 1.49
Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J Virol (1996) 1.49
Rubella complement fixing antigen prepared by alkaline extraction of virus grown in suspension culture of BHK-211 cells. Proc Soc Exp Biol Med (1967) 1.49
The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia (1984) 1.48
Serine protein kinase associated with varicella-zoster virus ORF 47. Virology (1992) 1.48
Doctors who do not feel sober enough to drive should avoid helping in medical emergencies. BMJ (1998) 1.47
Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax (1994) 1.46
Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology (1994) 1.46
Ocular Lyme borreliosis. Am J Ophthalmol (1989) 1.45
Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology (1986) 1.43
Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Eye (Lond) (2007) 1.43
Pyomyositis in an adolescent female athlete. J Pediatr Surg (1995) 1.43
Detection of persistent left superior vena cava by two-dimensional contrast echocardiography. J Clin Ultrasound (1979) 1.42
Mutation hot spots in 5q31-linked corneal dystrophies. Am J Hum Genet (1998) 1.42
Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis (1979) 1.40
Mammography after treatment for breast cancer. BMJ (1994) 1.40
Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI. J Virol (1993) 1.40
Beyond code teams: early defibrillation by nurses for in-hospital cardiac arrests. J Emerg Nurs (1992) 1.39
Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Virology (2006) 1.39
Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups. Stroke (2001) 1.39
Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles. J Infect Dis (1983) 1.39
Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology (1986) 1.39
Optimizing "delay period" for burst stimulation in dynamic cardiomyoplasty. Ann Thorac Surg (1995) 1.38
Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol (2001) 1.37
Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody. Virology (1993) 1.36
Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain. Virology (1998) 1.35
Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation (1980) 1.32
Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine. Arch Ophthalmol (1986) 1.31
Cytomegalovirus mononucleosis in a first trimester pregnant female with transmission to the fetus. Pediatrics (1971) 1.31
Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression. J Virol (2001) 1.29
Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor. Virology (1990) 1.29
Evaluation of serological techniques for titration of rubella antibody. Am J Public Health Nations Health (1969) 1.29
Interactions among structural proteins of varicella zoster virus. Arch Virol Suppl (2001) 1.27
The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (Lond) (2006) 1.26
The ocular manifestations of syphilis in the human immunodeficiency virus type 1-infected host. Ophthalmology (1990) 1.26
Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol (1998) 1.25
Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ (1997) 1.25
Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA (1978) 1.24
Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Virology (1986) 1.23
Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol (1990) 1.23